2B78.DE vs. ETLI.DE
2B78.DE (iShares Healthcare Innovation UCITS ETF) and ETLI.DE (L&G Pharma Breakthrough UCITS ETF) are both Health & Biotech Equities funds - 2B78.DE tracks the iSTOXX® FactSet Breakthrough Healthcare while ETLI.DE tracks the Solactive Pharma Breakthrough Value. Both are passively managed. Over the past 5 years, 2B78.DE returned -1.74%/yr vs 2.31%/yr for ETLI.DE. A 0.79 correlation means they provide meaningful diversification when combined. 2B78.DE charges 0.40%/yr vs 0.49%/yr for ETLI.DE.
Performance
2B78.DE vs. ETLI.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, 2B78.DE achieves a -2.07% return, which is significantly lower than ETLI.DE's -0.74% return.
2B78.DE
- 1D
- 0.41%
- 1M
- 1.41%
- YTD
- -2.07%
- 6M
- -3.15%
- 1Y
- 14.42%
- 3Y*
- 2.27%
- 5Y*
- -1.74%
- 10Y*
- —
ETLI.DE
- 1D
- 2.62%
- 1M
- -4.04%
- YTD
- -0.74%
- 6M
- -2.52%
- 1Y
- 22.46%
- 3Y*
- 2.83%
- 5Y*
- 2.31%
- 10Y*
- —
2B78.DE vs. ETLI.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
2B78.DE iShares Healthcare Innovation UCITS ETF | -2.07% | 5.50% | 7.24% | -0.29% | -19.03% | 1.15% | 38.75% | 16.74% | -5.52% |
ETLI.DE L&G Pharma Breakthrough UCITS ETF | -0.74% | 22.23% | 0.42% | -12.64% | -2.91% | 4.98% | 15.37% | 17.53% | -4.78% |
Correlation
The correlation between 2B78.DE and ETLI.DE is 0.74, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.74 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.76 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.79 |
Correlation (All Time) Calculated using the full available price history since Feb 26, 2018 | 0.79 |
The correlation between 2B78.DE and ETLI.DE has been stable across timeframes, ranging from 0.74 to 0.79 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
2B78.DE vs. ETLI.DE — Risk / Return Rank
2B78.DE
ETLI.DE
2B78.DE vs. ETLI.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF (2B78.DE) and L&G Pharma Breakthrough UCITS ETF (ETLI.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| 2B78.DE | ETLI.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.21 | ||
| Sortino ratioReturn per unit of downside risk | -0.32 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 1.20 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.24 | 2.40 | -1.17 |
| Martin ratioReturn relative to average drawdown | 3.07 | 6.79 | -3.72 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| 2B78.DE | ETLI.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.95 | 1.16 | -0.21 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.10 | 0.13 | -0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.22 | +0.09 |
Drawdowns
2B78.DE vs. ETLI.DE - Drawdown Comparison
The maximum 2B78.DE drawdown since its inception was -38.58%, which is greater than ETLI.DE's maximum drawdown of -30.83%. Use the drawdown chart below to compare losses from any high point for 2B78.DE and ETLI.DE.
Loading charts...
Drawdown Indicators
| 2B78.DE | ETLI.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.58% | -30.83% | -7.75% |
Max Drawdown (1Y)Largest decline over 1 year | -12.05% | -9.06% | -2.99% |
Max Drawdown (3Y)Largest decline over 3 years | -25.32% | -23.90% | -1.42% |
Max Drawdown (5Y)Largest decline over 5 years | -36.99% | -30.83% | -6.16% |
Current DrawdownCurrent decline from peak | -19.03% | -4.86% | -14.17% |
Average DrawdownAverage peak-to-trough decline | -14.36% | -10.22% | -4.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.86% | 3.21% | +1.65% |
Volatility
2B78.DE vs. ETLI.DE - Volatility Comparison
The current volatility for iShares Healthcare Innovation UCITS ETF (2B78.DE) is 3.74%, while L&G Pharma Breakthrough UCITS ETF (ETLI.DE) has a volatility of 6.89%. This indicates that 2B78.DE experiences smaller price fluctuations and is considered to be less risky than ETLI.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| 2B78.DE | ETLI.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.74% | 6.89% | -3.15% |
Volatility (6M)Calculated over the trailing 6-month period | 10.97% | 14.09% | -3.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.67% | 18.72% | -3.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.91% | 17.22% | +0.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.79% | 18.91% | -0.12% |
2B78.DE vs. ETLI.DE - Expense Ratio Comparison
2B78.DE has a 0.40% expense ratio, which is lower than ETLI.DE's 0.49% expense ratio.
Dividends
2B78.DE vs. ETLI.DE - Dividend Comparison
Neither 2B78.DE nor ETLI.DE has paid dividends to shareholders.
Frequently Asked Questions
2B78.DE and ETLI.DE have a correlation of 0.74, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, 2B78.DE is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
2B78.DE is cheaper with a 0.40% expense ratio, compared with 0.49% for ETLI.DE.
2B78.DE tracks iSTOXX® FactSet Breakthrough Healthcare, while ETLI.DE tracks Solactive Pharma Breakthrough Value. They also come from different issuers: iShares and Legal & General. Their fees differ too: 0.40% for 2B78.DE and 0.49% for ETLI.DE.
Find the right allocation for 2B78.DE and ETLI.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer